Trial intelligence / Profile preview

Genotype-Guided Antiplatelet Therapy in PCI

NCT01823185Phase 4Unknown

Sponsor
Imam Abdulrahman Bin Faisal University
Start
Mar 2013
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ticagrelor, prasugrel in coronary artery disease (CAD), myocardial infarction (MI), sponsored by Imam Abdulrahman Bin Faisal University. Status: unknown.

02

Drugs

ticagrelorprasugrel
03

Conditions

coronary artery disease (CAD)myocardial infarction (MI)

Beyond the preview

Go deeper on NCT01823185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01823185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call